We are live on ! Find out more
OMC

OUP Management Company Portfolio holdings

AUM $44.5M
1-Year Est. Return 55.11%
This Fund
S&P 500
This Quarter Est. Return
+37.99%
1 Year Est. Return
+55.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.6M
AUM Growth
+$8.53M
Cap. Flow
-$3.89M
Cap. Flow %
-6.63%
Top 10 Hldgs %
99.29%
Holding
14
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$2.4M
2
PRME icon
Prime Medicine
PRME
+$1.49M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$18.2M 31.01%
2,937,615
– –
DICE
2
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$12.5M 21.26%
268,346
– –
JBIO
3
Jade Biosciences
JBIO
$1.36B
$10.4M 17.66%
17,250
– –
CYT
4
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$6.39M 10.91%
2,459,572
– –
PMVP icon
5
PMV Pharmaceuticals
PMVP
$62.9M
$6.19M 10.56%
989,232
– –
VOR icon
6
Vor Biopharma
VOR
$1.24B
$1.16M 1.97%
18,736
– –
LENZ
7
LENZ Therapeutics
LENZ
$165M
$1.06M 1.8%
58,044
– –
RNAC icon
8
Cartesian Therapeutics
RNAC
$253M
$966K 1.65%
28,751
– –
EFTR
9
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$852K 1.45%
41,028
– –
DTIL icon
10
Precision BioSciences
DTIL
$192M
$591K 1.01%
37,464
– –
SPRO icon
11
Spero Therapeutics
SPRO
$72.4M
$361K 0.62%
249,070
– –
QTTB icon
12
Q32 Bio
QTTB
$493M
$56.6K 0.1%
3,556
– –
IONQ icon
13
IonQ
IONQ
$15.5B
– –
-389,668
Closed -$2.4M
PRME icon
14
Prime Medicine
PRME
$553M
– –
-121,255
Closed -$1.49M

Similar funds

JMF
Johnson Midwest Financial Glidden, Iowa $44.7M AUM 21.66% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
SIP
Scott Investment Partners Henley-On-Thames, United Kingdom $43.5M AUM 17.97% 1-Year Est. Return
KXA
KPCB XIV Associates Menlo Park, California $42.8M AUM 16.52% 1-Year Est. Return
WRCAI
West Rim Capital Associates II Lehi, Utah $46.8M AUM 11.72% 1-Year Est. Return
MAM
Must Asset Management Seoul, South Korea $40.9M AUM 22.53% 1-Year Est. Return
GIA
G2VP I Associates Portola Valley, California $48.2M AUM 37.59% 1-Year Est. Return

OUP Management Company's Q2 2023 Portfolio in Review

As of Q2 2023, OUP Management Company held 14 positions worth $58.6M, up 17% from $50.1M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

OUP Management Company withdrew a net $3.89M in Q2 2023, closing 2 positions. Its most notable exit was IonQ, an estimated $2.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 95% a quarter earlier, followed by Technology.

  • OUP Management Company fully exited IonQ in Q2 2023, selling an estimated $2.4M.
  • OUP Management Company's ten largest holdings make up 99% of its $58.6M portfolio in Q2 2023.
  • OUP Management Company opened 0 new positions and closed 2 in Q2 2023.
  • OUP Management Company's portfolio value rose 17% quarter-over-quarter to $58.6M.

Based on OUP Management Company's 13F filing for Q2 2023, filed 7 Aug 2023.